Sporadic Thyroid Gland Medullary Carcinoma
1 clinical trials · Condition
◉ Watch Sporadic Thyroid Gland Medullary Carcinoma
| Record | Firm | Date |
|---|---|---|
| Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer (NCT00390325) | National Cancer Institute (NCI) | 2006-11-03 |
Track Sporadic Thyroid Gland Medullary Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.